Drug Type Small molecule drug |
Synonyms CDA, Chlorproguanil/dapsone/artesunate, Dacart |
Target |
Mechanism ATP2A1 inhibitors(Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitors), DHPS inhibitors(Dihydropteroate synthase inhibitors), SERCA2 inhibitors(Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC12H12N2O2S |
InChIKeyMQJKPEGWNLWLTK-UHFFFAOYSA-N |
CAS Registry80-08-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malaria, Falciparum | Phase 3 | BF | 01 Apr 2006 | |
Malaria, Falciparum | Phase 3 | GH | 01 Apr 2006 | |
Malaria, Falciparum | Phase 3 | ML | 01 Apr 2006 | |
Malaria, Falciparum | Phase 3 | NG | 01 Apr 2006 | |
Malaria | Phase 3 | - | - | |
Malaria | Phase 3 | - | - |
Phase 3 | Malaria, Falciparum glucose-6-phosphate dehydrogenase (G6PD) | 1,372 | Chlorproguanil-dapsone-artesunate (CDA) | zhmzsogagt(flnisszogi) = fknusjagvb ixwbrnpbwk (klugdbtqcy ) View more | Negative | 19 Aug 2009 | |
Artemether-lumefantrine (AL) | zhmzsogagt(flnisszogi) = bqeaftqpjp ixwbrnpbwk (klugdbtqcy ) View more |